Showing 6101-6110 of 20929 results for "".
- Study: Strontium Cream Could Help Manage Pruritus in HShttps://reachmd.com/news/Study-Strontium-Cream-Could-Help-Manage-Pruritus-HS/2475142/Strontium cream demonstrated promise as a therapeutic option for managing pruritus in hidradenitis suppurativa (HS), according to new research published in the Journal of Clinical and Aesthetic Dermatology. Statistical analysis of baseline and 1-week post-intervention surveys amon
- Unveiling the Paradoxical Roles of Glucocorticoid Receptors in Prostate Cancerhttps://reachmd.com/news/unveiling-the-paradoxical-roles-of-glucocorticoid-receptors-in-prostate-cancer/2475117/The glucocorticoid receptor is increasingly recognized for its paradoxical roles in both advancing and restraining prostate cancer, spotlighting new therapeutic possibilities and obstacles. Oncologists dealing with prostate cancer must
- AB Chopra Epigenetics Launches With Plan to Revolutionize Longevityhttps://reachmd.com/news/ab-chopra-epigenetics-launches-with-plan-to-revolutionize-longevity/2475380/Charles Rosier, co-founder of the Augustinus Bader skincare and biotech company, and Deepak Chopra, MD, announced the launch of AB Chopra Epigenetics, a revolutionary longevity platform that merges advanced artificial intelligence, epigenetic science, and consciousness-based healing to redefine t
- Evolving Horizons in Asthma Treatment: The Rise of Biologic Therapieshttps://reachmd.com/news/evolving-horizons-in-asthma-treatment-the-rise-of-biologic-therapies/2475114/Emerging biologic therapies offer new approaches for managing severe asthma that do not respond to conventional treatments, providing information on current developments in biologic options for pulmonologists and allergy specialists. D
- AI-Driven Models Enhance Dialysis by Forecasting and Customizing Treatmentshttps://reachmd.com/news/ai-driven-models-enhance-dialysis-by-forecasting-and-customizing-treatments/2475112/Unpredictable fluid removal rates and solute clearance, compounded by individual patient variability, continue to challenge clinicians in delivering optimal dialysis. RRI’s
- AB Chopra Epigenetics Launches With Plan to Revolutionize Longevityhttps://reachmd.com/news/AB-Chopra-Epigenetics-Launches-With-Plan-Revolutionize-Longevity/2475124/Charles Rosier, co-founder of the Augustinus Bader skincare and biotech company, and Deepak Chopra, MD, announced the launch of AB Chopra Epigenetics, a revolutionary longevity platform that merges advanced artificial intelligence, epigenetic science, and consciousness-based healing to redefine t
- Antibiotics and Resistance: Rethinking Ciprofloxacin and Emerging Threatshttps://reachmd.com/news/antibiotics-and-resistance-rethinking-ciprofloxacin-and-emerging-threats/2475093/In the face of escalating antibiotic resistance, clinicians encounter the paradox where certain antibiotics, like ciprofloxacin, may inadvertently exert selection pressure, l
- Gut-Brain Axis Link to Neurodegeneration: New Frontiers in Parkinson’s and Alzheimer’shttps://reachmd.com/news/gut-brain-axis-link-to-neurodegeneration-new-frontiers-in-parkinsons-and-alzheimers/2475098/Emerging evidence warns that subtle disruptions in the gut-brain axis can accelerate cognitive decline in Parkinson’s disease and, conversely, that specific microbial compounds may decelerate Alzheimer’s pathology, redefining interve
- Late-Life Mood Disorders Signal Neurodegenerative Diseaseshttps://reachmd.com/news/late-life-mood-disorders-signal-neurodegenerative-diseases/2475099/Late-life mood disorders such as depression and bipolar disorder are increasingly recognized as potential early indicators of neurodegenerative diseases like dementia, challe
- Emerging Biologic Therapies in Rheumatoid Arthritis: A New Era of Treatmenthttps://reachmd.com/news/emerging-biologic-therapies-in-rheumatoid-arthritis-a-new-era-of-treatment/2475090/The therapeutic landscape for rheumatoid arthritis is evolving as emerging biologic therapies show promising efficacy and safety, potentially influencing treatment paradigms. Rheumatologists have long grappled with the limitations of s